Register

This webinar will discuss the next steps for ensuring that COVID-19 vaccines reach the public, including overcoming vaccine hesitancy, ensuring a robust supply chain, and communicating clearly and consistently throughout.

The webinar will begin with an introduction from the session's moderator, Jewel Mullen, Associate Dean for Health Equity at the University of Texas at Austin Dell Medical School, and then feature a conversation with a panel of experts, including:

• Paul Offit, Director, Vaccine Education Center, Children's Hospital of Philadelphia
• Katie Greene, Visiting Policy Associate, Duke-Margolis Center for Health Policy
• Julie Swann, Department Head, Edward P. Fitts Department of Industrial and Systems Engineering, NC State University
• Noel Brewer, Professor, Department of Health Behavior, University of North Carolina Gillings School of Global Public Health

The panel discussion will be followed by a Q&A session with the webinar audience.

This webinar has also been approved for 1.5 continuing education credits for CPH, CME, CNE or CHES. Several days after attending the webinar, participants will receive an email on how to claim their credits.

Watch free recordings of our webinars focused on social distancing, emerging evidence, crisis standards of care, testing, health equity, reopening America, mitigating indirect impacts, the road to immunity, clinical trials and therapeutics, reopening colleges and universities, managing ongoing surges, returning to K-12 education, and testing and contact tracing, as well as our most recent webinar on COVID-19 Vaccine Update: Development, Approval, Allocation, and Distribution in the U.S. Transcripts and slide presentations are also available for all webinars in this series.

The "COVID-19 Conversations" series of rapid-response webinars from the National Academy of Medicine and the American Public Health Association will address the state of the science on COVID-19 and explore emerging evidence on how to best mitigate its impact.

Led by a panel of expert advisors chaired by Carlos del Rio and Nicole Lurie, the series will feature trusted experts in such fields as public health, infectious disease, risk communication, and crisis standards of care. The series will provide trustworthy scientific analysis of important developments in the COVID-19 response to inform policymakers, public health practitioners, clinicians, business leaders, and scientists.